XNTR-938

N/A

Report date: 2023/03/31 16:26:05
NME

Base Information

Drug NameXNTR-938
Drug Alias NameXNTR-938
ClassificationSmall molecules
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonistsSTAT transcription factors inhibitors
TargetsEpidermal growth factor receptor erbB1STAT transcription factors
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXennials Therapeutics Australia Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXennials Therapeutics Australia Pty Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A